contact@asploro.com

Identifying Barriers to Therapeutic Adherence in Type 2-Diabetes: A Complex and Multidimensional Clinical Issue | Abstract

➣ Original Article

➣ Asp Biomed Clin Case Rep, vol.2, no.1: 22-28, 2019

Mujtaba Hasan Siddiqui1, Iqbal Akhtar Khan2*, Fauzia Moyeen3, Khawar Abbas Chaudhary4

1Department of Medicine, Akhtar Saeed Medical & Dental College, Lahore, Pakistan

2Independent Scholar, Lahore, Pakistan

3Consultant Diabetologoist, Diabetes Wellness Centre, Lahore, Pakistan

4Department of Medicine, Continental Medical College, Lahore, Pakistan

Corresponding Author: Prof. Iqbal Akhtar Khan, MBBS, DTM, FACTM, PhD

Address: Independent Scholar, Lahore, Pakistan.

Received date: 17 April 2019; Accepted date: 28 May 2019; Published date: 05 June 2019

Abstract

The problem of therapeutic non-adherence is a serious issue adversely affecting the adequate control and management of Type2 Diabetes (T2D).This unwelcoming situation has been studied well on various spots on the globe, with diverse results. The present study, aimed at identifying the barriers to therapeutic adherence, was conducted on a set of proven cases of T2D, managed by primary healthcare providers. The adherence rate to medication alone was 42% while to medication plus lifestyle recommendations 27%. Whereas sub-optimal health literacy, complexity of prescription and socioeconomic aspects were the main determinants, lapse on the part of healthcare system cannot be underscored. The present qualitative study was a preliminary investigation on a small sample .The magnitude of the problem necessitates that a large scale multi-centre in-depth quantitative study in 5 dimensions (recommended by WHO): socio-economic factors, health care team and system related factors, condition related factors , therapy related factors and patient related factors, be done on priority basis. This would pave the way for planning a well-designed intervention programme.

Citation: Siddiqui MH, Khan IA, Moyeen F, et al., “Identifying Barriers to Therapeutic Adherence in Type 2-Diabetes: A Complex and Multidimensional Clinical Issue”. Asp Biomed Clin Case Rep, vol.2, no.1: 22-28, 2019.

Copyright © 2019 Siddiqui MH, Khan IA, Moyeen F, et al., This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Key Words: Therapeutic Adherence; Type2 Diabetes; Non-Adherence; Under-Adherence; Over-Adherence

asploro

Asploro Open Access Publications Limited

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: